ArticleTranslational cancer research2019

Third line scenario in advanced non-small cell lung cancer: is the anti-angiogenetic strategy the only actor up to now?

Caterina Mecca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.